Product Information
CIPROFLOXACIN 0.3% EYE DROP is a generic product labeled by Leading Pharma, LLC, priced at $0.7964 per ML under NDC 69315030810. Its NADAC has been published 404 times since Jan 9, 2019.
FDA first approved this application on Jun 30, 2008. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
Leading Pharma, LLCNDC
69315030810
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077568FDA Approved
6/30/2008
TE Code
AT
On Market Since
11/1/2018
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN 0.3% EYE DROP has been published 404 times since Jan 9, 2019, and over the history we have for it it has declined 30.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7964 per ML |
|---|---|
| All-time high | $2.8216 (Feb 12, 2020) |
| All-time low | $0.7964 (Sep 23, 2026) |
| 52-week high | $1.2740 |
| 52-week low | $0.7964 |
| Median price | $1.4751 |
| Average price | $1.4329 |
| Largest weekly change | +56.3% (May 22, 2024) |
| Weeks tracked | 404 |
| Tracking since | Jan 9, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ciprofloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Fluoroquinolone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN 0.3% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN 0.3% EYE DROP, manufactured by Leading Pharma, LLC, is $0.7964 per ML (NDC 69315030810), effective Sep 30, 2026.
How has the price of CIPROFLOXACIN 0.3% EYE DROP changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN 0.3% EYE DROP has declined 30.3%. It has been tracked across 404 weekly CMS publications since Jan 9, 2019.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN 0.3% EYE DROP?
Since Jan 9, 2019, the NADAC for CIPROFLOXACIN 0.3% EYE DROP has ranged from a low of $0.7964 (Sep 23, 2026) to a high of $2.8216 (Feb 12, 2020), with a median of $1.4751 per ML.
Are there cheaper alternatives to CIPROFLOXACIN 0.3% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CIPROFLOXACIN 0.3% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures CIPROFLOXACIN 0.3% EYE DROP?
CIPROFLOXACIN 0.3% EYE DROP (NDC 69315030810) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.